Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea. 1972

D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003510 Cyclohexanes Six-carbon alicyclic hydrocarbons.
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi
March 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi
December 1972, La Clinica terapeutica,
D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi
July 1972, Arzneimittel-Forschung,
D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi
July 1979, Wiadomosci lekarskie (Warsaw, Poland : 1960),
D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi
January 1976, Bollettino della Societa italiana di cardiologia,
D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi
January 1979, Advances in experimental medicine and biology,
D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi
November 1963, Metabolism: clinical and experimental,
D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi
October 1958, Archivio "E. Maragliano" di patologia e clinica,
D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi
March 1978, Polskie Archiwum Medycyny Wewnetrznej,
D Fedele, and A Tiengo, and F Riva, and M Muggeo, and A Emanueli, and G Crepaldi
January 1973, La Prensa medica mexicana,
Copied contents to your clipboard!